COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,556 Articles (22,400 medRxiv, 8,156 bioRxiv)

Most recent first Previous |  Page 374: Articles 3731-3740  | Next

Unbiased spectral cytometry immunome characterization predicts COVID-19 mRNA vaccine failure in older adults and patients with lymphoid malignancies.
HERNANDEZ-VAZQUEZ, J., CAL-SABATER, P., ARRIBAS-RODRIGUEZ, E., FIZ-LOPEZ, A., PEREZ-SEGURADO, C., MARTIN-MUNOZ, A., DE PRADO-SANTOS, A., DE LA FUENTE-GRACIANI, I., PEREZ-GONZALEZ, S., GUTIERREZ, S., TELLERIA, P., NOVOA, C., ROJO-RELLO, S., GARCIA-BLESA, A., SEDANO, R., MARTINEZ-GARCIA, A. M., GARCINUNO-PEREZ, S., DOMINGUEZ-GIL, M., HERNAN-GARCIA, C., GUERRA, M. M., MUNOZ-SANCHEZ, E., BARRAGAN-PEREZ, C., DIEZ-MORALES, S., CASAZZA-DONNARUMMA, O., RAMOS-POLLO, D., SANTAMARTA-SOLLA, N., ALVAREZ-MANZANARES, P. M., BRAVO, S., GARCIA-ALONSO, C., TESEDO-NIETO, A., LOPEZ-MORENO, E. C., CABRERA-SANZ, M.
10.1101/2023.04.10.23288350 — Posted: 2023-04-10
NULISA: a novel proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing
Feng, W., Beer, J., Hao, Q., Ariyapala, I. S., Sahajan, A., Komarov, A., Cha, K., Moua, M., Qiu, X., Xu, X., Iyengar, S., Yoshimura, T., Nagaraj, R., Wang, L., Yu, M., Engel, K., Zhen, L., Xue, W., Lee, C.-j., Park, C. H., Peng, C., Zhang, K., Grzybowski, A., Hahm, J., Schmidt, S. V., Odainic, A., Spitzer, J., Bonn COVIMMUNE Consortium, , Buddika, K., Kuo, D., Fang, L., Zhang, B., Chen, S., Latz, E., Yin, Y., Luo, Y., Ma, X.-J.
10.1101/2023.04.09.536130 — Posted: 2023-04-10
Antibodies that neutralize all current SARS-CoV-2 variants of concern by conformational locking
Liu, L., Casner, R. G., Guo, Y., Wang, Q., Iketani, S., Chan, J. F.-W., Yu, J., Dadonaite, B., Nair, M. S., Mohri, H., Reddem, E. R., Yuan, S., Poon, V. K.-M., Chan, C. C.-S., Yuen, K.-Y., Sheng, Z., Huang, Y., Bloom, J. D., Shapiro, L., Ho, D. D.
10.1101/2023.04.08.536123 — Posted: 2023-04-10
SARS-CoV-2's evolutionary capacity is mostly driven by host antiviral molecules
Lamb, K. D., Luka, M. M., Saathoff, M., Orton, R., Phan, M., Cotten, M., Yuan, K., Robertson, D. L.
10.1101/2023.04.07.536037 — Posted: 2023-04-10
Association between PM2.5 air pollution, temperature, and sunlight during different infectious stages with the case fatality of COVID-19 in the United Kingdom: a modeling study
Hossain, M. P., Zhou, W., Leung, M. Y. T., Yuan, H.-Y.
10.1101/2023.04.07.23288300 — Posted: 2023-04-09
COVID-19 Vaccine Uptake And Its Associated Factors among general population In Basmaia City in Baghdad 2022
Alhlew, H. A., Albayaty, M. A.
10.1101/2023.04.07.23288262 — Posted: 2023-04-09
A new tractable method for generating Human Alveolar Macrophage Like cells in vitro to study lung inflammatory processes and diseases
Pahari, S., Arnett, E., Simper, J., Azad, A., Guerrero-Arguero, I., Ye, C., Zhang, H., Cai, H., Wang, Y., Lai, Z., Jarvis, N., Lumbreras, M., Maselli-Caceres, D. J., Peters, J. I., Torrelles, J. B., Mart ínez-Sobrido, L., Schlesinger, L. S.
10.1101/2023.04.05.535806 — Posted: 2023-04-08
Integration of serial self-testing for COVID-19 as part of contact tracing in the Brazilian public health system: A pragmatic trial protocol
Green, R., Manchola, C., Gerth-Guyette, E., Oliveira Silva, M., Stephanie, R., dos Santos Soares, T., Bastos Gottin, L., Coelho, M., Green, K. E., Dias Tavares Costa, A., Batista Pereira, D.
10.1101/2023.04.05.23288207 — Posted: 2023-04-07
Silymarin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells
Nnadi, N. E., Luka, P. D., Omale, S., Shehu, N. Y., Aguiyi, J. C.
10.1101/2023.04.07.535766 — Posted: 2023-04-07
The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 Gamma variant
Pegg, C. L., Modhiran, N., Parry, R., Liang, B., Amarilla, A. A., Khromykh, A., Burr, L., Young, P., Chappell, K., Schulz, B. L., Watterson, D.
10.1101/2023.04.03.535004 — Posted: 2023-04-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).